Clinical Trials in New York

Showing 4961-4980 of 17,259 trials

A Study of Etigilimab and Nivolumab in Participants With Locally Advanced or Metastatic Tumors

NCT04761198

This is an open-label, phase 1b/2, multicenter study designed to evaluate the efficacy, safety, tolerability, pharmacokinetics (PK), and pharmacodynamics of etigilimab in combination with nivolumab in participants with locally advanced or metastatic solid tumors. Participants will be assigned to receive etigilimab (every 2 weeks) in combination with nivolumab (240 milligrams \[mg\] every 2 weeks).

Solid Tumor, AdultAdvanced Solid TumorMetastatic Solid Tumor

Mereo BioPharma76 participantsStarted Mar 2021

Phoenix, Arizona, United States • Greenbrae, California, United States • Los Angeles, California, United States +13 more locations

COMPLETEDPhase 1< 1 mile

An Open-Label Study Following Oral Dosing of Seladelpar to Subjects With Primary Biliary Cholangitis (PBC) and Hepatic Impairment (HI)

NCT04950764

The Effect of Hepatic Impairment on The Pharmacokinetics of Seladelpar: An Open-Label Study Following Oral Dosing of Seladelpar to Subjects with Primary Biliary Cholangitis (PBC) and Hepatic Impairment (HI)

Primary Biliary CholangitisCompensated CirrhosisHepatic Impairment

Gilead Sciences24 participantsStarted Sep 2021

Chandler, Arizona, United States • Sacramento, California, United States • Aurora, Colorado, United States +17 more locations

A Study of Etigilimab and Nivolumab in Participants With Locally Advanced or Metastatic Tumors

An Open-Label Study Following Oral Dosing of Seladelpar to Subjects With Primary Biliary Cholangitis (PBC) and Hepatic Impairment (HI)

Find Trials by Condition in New York

Metal Ion Levels in Stryker Trident II Tritanium System with Modular Dual Mobility (MDM) Liner, Ceramic Head, and SecurFit Advanced Stems

Evaluating the Impact of Patient Photographs for Preventing Wrong-Patient Errors

A Study Evaluating the Safety and Efficacy of Lovo-cel in Severe Sickle Cell Disease

Clinical Trial to Evaluate Safety and Efficacy of CCX168 in ANCA-Associated Vasculitis

The Effects of Daily Anti-inflammatory Supplementation on Foundation Pain Index Scores in Chronic Opiate Patients

Improving How People Living With Dementia Are Selected for Care Coordination

A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer

Gain and Loss Framed Text Messaging to Reduce Drinking Among Older Adults

A Study of INCB050465 in Relapsed or Refractory Follicular Lymphoma

SNV1521 in Participants with Advanced Solid Tumors

p53 Suppressor Activation in Recurrent High Grade Serous Ovarian Cancer, a Phase Ib/II Study of Systemic Carboplatin Combination Chemotherapy With or Without APR-246

Trial to Shorten Pharmacologic Treatment of Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS)

An Evaluation of LEO 138559 in Adults With Moderate to Severe Atopic Dermatitis.

Open-Label Study to Evaluate Safety and Efficacy of CCX168 in Subjects With IGA Nephropathy on Stable RAAS Blockade

Angio-IMR and Cardiac MR-derived MVO in STEMI Patients

Prognostic Impact of Cardiac Diastolic Function and Coronary Microvascular Function

Safety and Immunogenicity of HIL-214 With Routine Pediatric Vaccines

Pivotal, Clinical Study for the Accuracy Evaluation of the IdentiClone Dx TRG Assay